廣告
香港股市 已收市
  • 恒指

    18,335.32
    -95.07 (-0.52%)
     
  • 國指

    6,556.10
    -31.67 (-0.48%)
     
  • 上證綜指

    3,005.44
    -12.61 (-0.42%)
     
  • 道指

    38,834.86
    +56.76 (+0.15%)
     
  • 標普 500

    5,487.03
    +13.80 (+0.25%)
     
  • 納指

    17,862.23
    +5.21 (+0.03%)
     
  • Vix指數

    12.57
    +0.09 (+0.72%)
     
  • 富時100

    8,231.56
    +26.45 (+0.32%)
     
  • 紐約期油

    81.73
    +0.16 (+0.20%)
     
  • 金價

    2,353.00
    +6.10 (+0.26%)
     
  • 美元

    7.8036
    -0.0026 (-0.03%)
     
  • 人民幣

    0.9298
    +0.0007 (+0.08%)
     
  • 日圓

    0.0490
    -0.0001 (-0.31%)
     
  • 歐元

    8.3631
    -0.0241 (-0.29%)
     
  • Bitcoin

    66,255.02
    +1,006.44 (+1.54%)
     
  • CMC Crypto 200

    1,374.38
    -8.28 (-0.60%)
     

Insmed Stock Surges on Trial Win for Lung-Condition Drug. ‘We Hit the Mark,’ CEO Says.

Insmed Stock Surges on Trial Win for Lung-Condition Drug. ‘We Hit the Mark,’ CEO Says.

Analysts had said shares could more than double if the trial was a success, or fall by more than half if it failed. The drug brensocatib, treats a condition called bronchiectasis.